EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Radioiodination, purification, and evaluation of antihuman tumor‐derived immunoglobulin G light chain monoclonal antibody in tumor‐bearing nude mice

Hongwei Sun iD, Ping Yan, Rongfu Wang, Yujing Du, Chunli Zhang, Fengqin Guo, Lei Kang, Yonggang Cui

Journal of Labelled Compounds and Radiopharmaceuticals · 2023

DOI: 10.1002/jlcr.4017 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Labelled Compounds and Radiopharmaceuticals, 2023. Verfasst von Hongwei Sun und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Peking University First Hospital, Beijing, China. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We report the synthesis and biological evaluation of 131 I‐labeled antihuman tumor‐derived immunoglobulin G (IgG) light chain monoclonal antibody (4E9) ([ 131 I]I‐4E9) as a promising probe for tumor imaging. [ 131 I]I‐4E9 was synthesized in radiochemical yield of 89.9 ± 4.7% with radiochemical purity of more than 99%. [ 131 I]I‐4E9 showed high stability in normal saline and human serum. In cell uptake studies, [ 131 I]I‐4E9 exhibited favorable binding affinity and high specificity in HeLa MR cells. In biodistribution studies, [ 131 I]I‐4E9 showed high tumor uptake, high tumor/non‐tumor ratios, and specific binding in BALB/c nu/nu mice bearing human HeLa MR xenografts. Single‐photon emission computerized tomography (SPECT) imaging of [ 131 I]I‐4E9 in the HeLa MR xenograft model demonstrated clear visualization of tumor after 48 h and confirmed specific binding in tumor. These findings suggest that [ 131 I]I‐4E9 possesses favorable biological characteristics and warrants further investigation as a prospective probe for imaging and treatment of cancers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, MonoclonalNeoplasmsAnimalsMiceHumansMice, NudeIodine RadioisotopesImmunoglobulin Light ChainsImmunoglobulin GTissue DistributionProspective StudiesTomography, Emission-Computed, Single-PhotonCell Line, Tumor

Stichwörter der Autor:innen

antihuman tumor-derived IgG light chain monoclonal antibody (4E9)radioiodinationradionuclide imaging

Substanzen

Antibodies, MonoclonalIodine RadioisotopesImmunoglobulin Light ChainsImmunoglobulin G

Autor:innen und Institutionen

  • Department of Nuclear Medicine, Peking University First Hospital, Beijing, China.
  • Department of Nuclear Medicine, Peking University International Hospital, Beijing, China.

ORCID-Profile: Hongwei Sun

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Sun, H., Yan, P., Wang, R., Du, Y., Zhang, C., Guo, F., Kang, L., & Cui, Y. (2023). Radioiodination, purification, and evaluation of antihuman tumor‐derived immunoglobulin G light chain monoclonal antibody in tumor‐bearing nude mice. Journal of Labelled Compounds and Radiopharmaceuticals. https://doi.org/10.1002/jlcr.4017

Vancouver

Sun H, Yan P, Wang R, Du Y, Zhang C, Guo F, et al. Radioiodination, purification, and evaluation of antihuman tumor‐derived immunoglobulin G light chain monoclonal antibody in tumor‐bearing nude mice. Journal of Labelled Compounds and Radiopharmaceuticals. 2023. doi:10.1002/jlcr.4017

BibTeX
@article{Sun2023,
  author = {Sun, Hongwei and Yan, Ping and Wang, Rongfu and Du, Yujing and Zhang, Chunli and Guo, Fengqin and Kang, Lei and Cui, Yonggang},
  title = {Radioiodination, purification, and evaluation of antihuman tumor‐derived immunoglobulin G light chain monoclonal antibody in tumor‐bearing nude mice},
  journal = {Journal of Labelled Compounds and Radiopharmaceuticals},
  year = {2023},
  doi = {10.1002/jlcr.4017}
}
Kostenlos starten →